BlackRock's position in CVS Health is currently worth $11.9B. That's 0.18% of their equity portfolio (88th largest holding). The investor owns 10.29% of the outstanding CVS Health stock. The first CVS Health trade was made in Q4 2020. Since then BlackRock bought shares thirteen more times and sold shares on four occasions. The stake costed the investor $8.25B, netting the investor a gain of 45% so far.
Senator John Boozman (R-Arkansas) recently sold shares of Union Pacific Corporation (NYSE: UNP). In a filing disclosed on February 15th, the Senator disclose...
Senator John Boozman (R-Arkansas) recently sold shares of iShares Russell 2000 ETF (NYSEARCA:IWM). In a filing disclosed on February 15th, the Senator disclo...
Senator John Boozman (R-Arkansas) recently sold shares of Fiserv, Inc. (NASDAQ: FISV). In a filing disclosed on February 15th, the Senator disclosed that the...
Senator John Boozman (R-Arkansas) recently bought shares of CVS Health Corporation (NYSE: CVS). In a filing disclosed on February 15th, the Senator disclosed...